Literature DB >> 24554338

Constant high adrenal FDG uptake in PET/CT associated with mitochondrial disease.

Mika H Martikainen1, Ulla Hohenthal, Laura Pirilä, Jukka Kemppainen.   

Abstract

We describe a patient with the m.3243A>G mitochondrial DNA mutation who developed sepsis caused by Streptococcus constellatus. In the acute phase of illness, abnormally high uptake of (18)F-FDG was observed in both adrenal glands that appeared anatomically normal. In repeated imaging six months later the adrenal uptake had diminished but remained clearly elevated. We did not observe high adrenal FDG uptake as in the patient described here among 30 patients with Staphylococcus aureus sepsis that were investigated with identical imaging protocol. In sepsis, oxygen consumption and metabolic rate are increased compared to normal metabolism. The observed high adrenal FDG uptake during sepsis in this patient probably reflects the acute metabolic stress induced by the infection. Interestingly, in repeated imaging six months later, the adrenal SUVs had diminished but were still abnormally high: this suggests constant high levels of metabolic stress associated with the mitochondrial disorder.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24554338     DOI: 10.1007/s10545-014-9685-8

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  3 in total

1.  Transient adrenal gland uptake of gallium during septicemia.

Authors:  Lawrence Parker; Edgar Moran; Sing-Yung Wu
Journal:  Semin Nucl Med       Date:  2002-07       Impact factor: 4.446

2.  Bilateral adrenocortical uptake of Ga-67 SPECT during septicemia in a heart transplant patient.

Authors:  Francisco José Pena; Remedios Quirce; Roberto H Allende; Ignacio Banzo; José Manuel Carril
Journal:  Clin Nucl Med       Date:  2005-05       Impact factor: 7.794

3.  Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock.

Authors:  G Kreymann; S Grosser; P Buggisch; C Gottschall; S Matthaei; H Greten
Journal:  Crit Care Med       Date:  1993-07       Impact factor: 7.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.